Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Outlook Therapeutics (OTLK) Q2 2025 Earnings
OTLK
15
May
Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.03
-0.82
-0.61
-0.4
Details
Expected EPS
-0.54282
Actual EPS
-0.4
Surprise EPS
0.14
Surprise Percent
+26.31%
Description
Outlook Therapeutics (OTLK) has reported earnings of -0.4 per share for Q2 2025.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login